Vevoctadekin Monoclonal Antibody
Vevoctadekinis a research-grade recombinant antibody targeting IFN-gamma-inducing factor. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
IFN-gamma-inducing factor, IL1F4, Interleukin-1 gamma, IL-18, IL-1 gamma, Interleukin-18, Interferon gamma-inducing factor, IGIF, IL18, Iboctadekin
UniProt
Q14116
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Purified by Nickel column.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
Human IL18 fragment
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Escherichia coli O127:H6 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG)
Recombinant Escherichia coli O127:H6 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG)
Recombinant Escherichia coli O127:H6 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG)
Recombinant Escherichia coli O127:H6 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG)
Recombinant Escherichia coli O127:H6 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG)